This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ruedl, C.
Right arrow Articles by Bachmann, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ruedl, C.
Right arrow Articles by Bachmann, M. F.

 Previous Article  |  Next Article 

Journal of Virology, January 2005, p. 717-724, Vol. 79, No. 2
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.2.717-724.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.

Virus-Like Particles as Carriers for T-Cell Epitopes: Limited Inhibition of T-Cell Priming by Carrier-Specific Antibodies

Christiane Ruedl, Katrin Schwarz, Andrea Jegerlehner, Tazio Storni, Vania Manolova, and Martin F. Bachmann*

Cytos Biotechnology AG, Schlieren-Zürich, Switzerland

Received 15 July 2004/ Accepted 4 August 2004

Virus-like particles (VLPs) are able to induce cytotoxic T-cell responses in the absence of infection or replication. This makes VLPs promising candidates for the development of recombinant vaccines. However, VLPs are also potent inducers of B-cell responses, and it is generally assumed that such VLP-specific antibodies interfere with the induction of protective immune responses, a phenomenon summarized as carrier suppression. In this study, we investigated the impact of preexisting VLP-specific antibodies on the induction of specific cytotoxic T-cell and Th-cell responses in mice. The data show that VLP-specific antibodies did not measurably reduce antigen presentation in vitro or in vivo. Nevertheless, T-cell priming was slightly reduced by antigen-specific antibodies; however, the overall reduction was limited and vaccination with VLPs in the presence of VLP-specific antibodies still resulted in protective T-cell responses. Thus, carrier suppression is unlikely to be a limiting factor for VLP-based T-cell vaccines.


* Corresponding author. Mailing address: Cytos Biotechnology AG, Wagistrasse 25, 8952 Schlieren-Zürich, Switzerland. Phone: 41 1 733 40 23. Fax: 41 1 733 47 04. E-mail: martin.bachmann{at}cytos.com.


Journal of Virology, January 2005, p. 717-724, Vol. 79, No. 2
0022-538X/05/$08.00+0     doi:10.1128/JVI.79.2.717-724.2005
Copyright © 2005, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Buonaguro, L., Tornesello, M. L., Gallo, R. C., Marincola, F. M., Lewis, G. K., Buonaguro, F. M. (2009). Th2 Polarization in Peripheral Blood Mononuclear Cells from Human Immunodeficiency Virus (HIV)-Infected Subjects, as Activated by HIV Virus-Like Particles. J. Virol. 83: 304-313 [Abstract] [Full Text]  
  • Li, M., Bharadwaj, U., Zhang, R., Zhang, S., Mu, H., Fisher, W. E., Brunicardi, F. C., Chen, C., Yao, Q. (2008). Mesothelin is a malignant factor and therapeutic vaccine target for pancreatic cancer. Molecular Cancer Therapeutics 7: 286-296 [Abstract] [Full Text]  
  • Ryding, J., Dahlberg, L., Wallen-Ohman, M., Dillner, J. (2007). Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles. J. Gen. Virol. 88: 792-802 [Abstract] [Full Text]  
  • Koudelka, K. J., Rae, C. S., Gonzalez, M. J., Manchester, M. (2007). Interaction between a 54-Kilodalton Mammalian Cell Surface Protein and Cowpea Mosaic Virus. J. Virol. 81: 1632-1640 [Abstract] [Full Text]  
  • Buonaguro, L., Tornesello, M. L., Tagliamonte, M., Gallo, R. C., Wang, L. X., Kamin-Lewis, R., Abdelwahab, S., Lewis, G. K., Buonaguro, F. M. (2006). Baculovirus-derived human immunodeficiency virus type 1 virus-like particles activate dendritic cells and induce ex vivo T-cell responses.. J. Virol. 80: 9134-9143 [Abstract] [Full Text]